Figure 5
Heart failure symptoms at baseline and at the 1-year follow-up. Baseline heart failure symptoms did not differ between the two groups. In contrast, the transcatheter mitral valve repair (TMVr) group had a significantly higher prevalence of the New York Heart Association (NYHA) class I than the control group at the 1-year follow-up.

Heart failure symptoms at baseline and at the 1-year follow-up. Baseline heart failure symptoms did not differ between the two groups. In contrast, the transcatheter mitral valve repair (TMVr) group had a significantly higher prevalence of the New York Heart Association (NYHA) class I than the control group at the 1-year follow-up.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close